This is an AMP page which is for mobile devices.
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
home / news releases / IBRX - ImmunityBio immunotherapy shows positive overall survival in lung cancer trial
2024-04-25 07:44:32 ET
Shares of ImmunityBio ( NASDAQ: IBRX ) rose as much as 17% premarket on Thursday after the biotech reported positive overall survival results from a trial evaluating its immunotherapy drug, Anktiva, in non-small cell lung cancer (NSCLC)....
ImmunityBio immunotherapy shows positive overall survival in lung cancer trialNews, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.